These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15093794)

  • 1. An evaluation of the use of the transdermal contraceptive patch in adolescents.
    Rubinstein ML; Halpern-Felsher BL; Irwin CE
    J Adolesc Health; 2004 May; 34(5):395-401. PubMed ID: 15093794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
    Harel Z; Riggs S; Vaz R; Flanagan P; Dunn K; Harel D
    J Pediatr Adolesc Gynecol; 2005 Apr; 18(2):85-90. PubMed ID: 15897103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical study of transdermal contraceptive patch in Thai adolescence women.
    Piyasirisilp R; Taneepanichskul S
    J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical study of transdermal contraceptive patch in Thai women.
    Suwanmalee O; Taneepanichskul S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S1-4. PubMed ID: 17726805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term evaluation of the use of the transdermal contraceptive patch in adolescents.
    Logsdon S; Richards J; Omar HA
    ScientificWorldJournal; 2004 Jul; 4():512-6. PubMed ID: 15258678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transdermal contraceptive patch: a new approach to hormonal contraception.
    Burkman RT
    Int J Fertil Womens Med; 2002; 47(2):69-76. PubMed ID: 11991433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users.
    Bodner K; Bodner-Adler B; Grünberger W
    Arch Gynecol Obstet; 2011 Mar; 283(3):525-30. PubMed ID: 20111970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy.
    Archer DF; Cullins V; Creasy GW; Fisher AC
    Contraception; 2004 Mar; 69(3):189-95. PubMed ID: 14969665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
    Stewart FH; Kaunitz AM; Laguardia KD; Karvois DL; Fisher AC; Friedman AJ
    Obstet Gynecol; 2005 Jun; 105(6):1389-96. PubMed ID: 15932834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study.
    Weisberg F; Bouchard C; Moreau M; Audet MC; Mawdsley S; Dattani D; Dinniwell J; Horbay GL;
    J Obstet Gynaecol Can; 2005 Apr; 27(4):350-9. PubMed ID: 15937609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ortho Evra, a new contraceptive patch.
    Sicat BL
    Pharmacotherapy; 2003 Apr; 23(4):472-80. PubMed ID: 12680477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women.
    Archer DF; Bigrigg A; Smallwood GH; Shangold GA; Creasy GW; Fisher AC
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S27-31. PubMed ID: 11849633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medication of the month. Evra: first contraceptive transdermal patch].
    Gaspard U
    Rev Med Liege; 2003 Nov; 58(11):709-12. PubMed ID: 14748201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).
    Sibai BM; Odlind V; Meador ML; Shangold GA; Fisher AC; Creasy GW
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S19-26. PubMed ID: 11849632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2004 Jan; 30(1):43-5. PubMed ID: 15006313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
    Goa KL; Warner GT; Easthope SE
    Treat Endocrinol; 2003; 2(3):191-206. PubMed ID: 15966567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
    White T; Jain JK; Stanczyk FZ
    Am J Obstet Gynecol; 2005 Jun; 192(6):2055-9. PubMed ID: 15970897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evra--a patch on oral contraception?
    Drug Ther Bull; 2003 Dec; 41(12):89-91. PubMed ID: 14723093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A transdermal form of combined hormonal contraceptives (EVRA)].
    Fanta M
    Ceska Gynekol; 2003 Oct; 68(5):341-5. PubMed ID: 14692356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.